1. Home
  2. CVAC vs UMH Comparison

CVAC vs UMH Comparison

Compare CVAC & UMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • UMH
  • Stock Information
  • Founded
  • CVAC 2000
  • UMH 1968
  • Country
  • CVAC Germany
  • UMH United States
  • Employees
  • CVAC N/A
  • UMH N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • UMH Real Estate Investment Trusts
  • Sector
  • CVAC Health Care
  • UMH Real Estate
  • Exchange
  • CVAC Nasdaq
  • UMH Nasdaq
  • Market Cap
  • CVAC 1.2B
  • UMH 1.3B
  • IPO Year
  • CVAC 2020
  • UMH N/A
  • Fundamental
  • Price
  • CVAC $5.41
  • UMH $14.08
  • Analyst Decision
  • CVAC Hold
  • UMH Buy
  • Analyst Count
  • CVAC 3
  • UMH 2
  • Target Price
  • CVAC $6.83
  • UMH $17.75
  • AVG Volume (30 Days)
  • CVAC 404.4K
  • UMH 747.5K
  • Earning Date
  • CVAC 11-11-2025
  • UMH 11-03-2025
  • Dividend Yield
  • CVAC N/A
  • UMH 6.37%
  • EPS Growth
  • CVAC N/A
  • UMH N/A
  • EPS
  • CVAC 1.01
  • UMH 0.13
  • Revenue
  • CVAC $599,540,810.00
  • UMH $250,046,000.00
  • Revenue This Year
  • CVAC N/A
  • UMH $6.77
  • Revenue Next Year
  • CVAC $23.83
  • UMH $5.32
  • P/E Ratio
  • CVAC $5.40
  • UMH $110.51
  • Revenue Growth
  • CVAC 675.15
  • UMH 8.49
  • 52 Week Low
  • CVAC $2.37
  • UMH $14.09
  • 52 Week High
  • CVAC $5.72
  • UMH $20.42
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 53.41
  • UMH 27.26
  • Support Level
  • CVAC $5.33
  • UMH $14.39
  • Resistance Level
  • CVAC $5.45
  • UMH $14.79
  • Average True Range (ATR)
  • CVAC 0.03
  • UMH 0.29
  • MACD
  • CVAC 0.01
  • UMH -0.04
  • Stochastic Oscillator
  • CVAC 66.10
  • UMH 0.39

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About UMH UMH Properties Inc.

UMH Properties Inc together with its subsidiaries is a real estate investment trust. It is engaged in the business of ownership and operation of manufactured home communities - leasing manufactured homesites to residents . The Company also leases manufactured homes to residents and, through its wholly-owned taxable REIT subsidiary, UMH Sales and Finance, Inc. sells and finances the sale of manufactured homes to residents and prospective residents of its communities and for placement on customers' privately-owned land. The company also owns the land, utility connections, streets, lighting, driveways, common area amenities, and other capital improvements. It earns income from lease agreements for their sites and homes, where the company is the lessor.

Share on Social Networks: